A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts

NCT00130325 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

214

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Isoniazid
DRUG: Isoniazid
DRUG: Placebo of Isoniazid tablets 300mg

Sponsor

Medical Research Council Unit, The Gambia